BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 11
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study
©The Author(s) 2015.
World J Hepatol. Jun 18, 2015; 7(11): 1586-1594
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1586
Table 2 Summary of the characteristics of participants (n = 442)
Characteristics
Age (yr)49.1 ± 14.2
Gender
Female290 (65.6)
Male152 (34.4)
BMI (kg/m2)31.3 ± 6.1
Hepatic steatosis230 (52.0)
Elevated ALT1128 (29.0)
Elevated AST2129 (29.2)
Albumin (g/dL)4.0 (3.8-4.2)
Platelet (109/μL)243.5 (207.0-282.0)
DM397 (21.9)
Hypertension167 (37.8)
Hyperglycemia134 (30.3)
Hypertriglyceridemia175 (39.6)
Low HDL-C267 (60.4)
Central obesity324 (73.3)
Metabolic syndrome219 (49.5)
NAFLD fibrosis score
< -1.455244 (55.2)
-1.455-0.676169 (38.2)
> 0.67629 (6.6)
FIB4 index
≤ 1.31323 (73.1)
1.31-2.66106 (24.0)
≥ 2.6713 (2.9)
BARD
0-1163 (36.9)
2-4279 (63.1)
APRI
≤ 0.5365 (82.6)
0.51-1.573 (16.5)
> 1.54 (0.9)
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.